These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28506555)

  • 21. Therapeutic Prospect of New Probiotics in Neurodegenerative Diseases.
    Bi M; Liu C; Wang Y; Liu SJ
    Microorganisms; 2023 Jun; 11(6):. PubMed ID: 37375029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut Microbiota and Its Repercussion in Parkinson's Disease: A Systematic Review in Occidental Patients.
    Proano AC; Viteri JA; Orozco EN; Calle MA; Costa SC; Reyes DV; German-Montenegro M; Moncayo DF; Tobar AC; Moncayo JA
    Neurol Int; 2023 Jun; 15(2):750-763. PubMed ID: 37368331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parkinson's disease: Are gut microbes involved?
    Omotosho AO; Tajudeen YA; Oladipo HJ; Yusuff SI; AbdulKadir M; Muili AO; Egbewande OM; Yusuf RO; Faniran ZO; Afolabi AO; El-Sherbini MS
    Brain Behav; 2023 Aug; 13(8):e3130. PubMed ID: 37340511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the Microbiome.
    Bicknell B; Liebert A; Borody T; Herkes G; McLachlan C; Kiat H
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastrointestinal disorders in Parkinson's disease and other Lewy body diseases.
    Hirayama M; Nishiwaki H; Hamaguchi T; Ohno K
    NPJ Parkinsons Dis; 2023 May; 9(1):71. PubMed ID: 37147392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gut Microbiota and Its Role in Anti-aging Phenomenon: Evidence-Based Review.
    Li R; Roy R
    Appl Biochem Biotechnol; 2023 Nov; 195(11):6809-6823. PubMed ID: 36930406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered gut microbiota in patients with idiopathic Parkinson's disease: an age-sex matched case-control study.
    Babacan Yildiz G; Kayacan ZC; Karacan I; Sumbul B; Elibol B; Gelisin O; Akgul O
    Acta Neurol Belg; 2023 Jun; 123(3):999-1009. PubMed ID: 36719617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut Microbial Alteration in MPTP Mouse Model of Parkinson Disease is Administration Regimen Dependent.
    Aktas B
    Cell Mol Neurobiol; 2023 Aug; 43(6):2815-2829. PubMed ID: 36708421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High levels of
    Zuo S; Wang H; Zhao Q; Tang J; Wang M; Zhang Y; Sang M; Tian J; Wang P
    Front Integr Neurosci; 2022; 16():1054627. PubMed ID: 36686268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Updates on the Role of Probiotics against Different Health Issues: Focus on
    Un-Nisa A; Khan A; Zakria M; Siraj S; Ullah S; Tipu MK; Ikram M; Kim MO
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut microbiota in dementia with Lewy bodies.
    Nishiwaki H; Ueyama J; Kashihara K; Ito M; Hamaguchi T; Maeda T; Tsuboi Y; Katsuno M; Hirayama M; Ohno K
    NPJ Parkinsons Dis; 2022 Dec; 8(1):169. PubMed ID: 36494405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Gastrointestinal Symptoms on Health-Related Quality of Life in an Australian Parkinson's Disease Cohort.
    Kenna JE; Bakeberg MC; Abonnel MY; Mastaglia FL; Anderton RS
    Parkinsons Dis; 2022; 2022():4053665. PubMed ID: 36466568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parkinson's Disease and the Gut Microbiome in Rural California.
    Zhang K; Paul KC; Jacobs JP; Chou HL; Duarte Folle A; Del Rosario I; Yu Y; Bronstein JM; Keener AM; Ritz B
    J Parkinsons Dis; 2022; 12(8):2441-2452. PubMed ID: 36442206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What Are the Key Gut Microbiota Involved in Neurological Diseases? A Systematic Review.
    Bonnechère B; Amin N; van Duijn C
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rifaximin Modifies Gut Microbiota and Attenuates Inflammation in Parkinson's Disease: Preclinical and Clinical Studies.
    Hong CT; Chan L; Chen KY; Lee HH; Huang LK; Yang YSH; Liu YR; Hu CJ
    Cells; 2022 Nov; 11(21):. PubMed ID: 36359864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Interplay between Gut Microbiota and Parkinson's Disease: Implications on Diagnosis and Treatment.
    Varesi A; Campagnoli LIM; Fahmideh F; Pierella E; Romeo M; Ricevuti G; Nicoletta M; Chirumbolo S; Pascale A
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNA-based stable isotope probing provides no indication for rapid α-synuclein assimilation by murine gut bacteria.
    Brandau L; Weis S; Weyland M; Berger FK; Schnell S; Schäfer KH; Egert M
    Access Microbiol; 2022 Aug; 4(5):acmi000345. PubMed ID: 36003361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut Microbes and Neuropathology: Is There a Causal Nexus?
    Dinan K; Dinan TG
    Pathogens; 2022 Jul; 11(7):. PubMed ID: 35890040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Gut Microbiome-Brain Crosstalk in Neurodegenerative Diseases.
    Ghezzi L; Cantoni C; Rotondo E; Galimberti D
    Biomedicines; 2022 Jun; 10(7):. PubMed ID: 35884791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct Bile Acid Signature in Parkinson's Disease With Mild Cognitive Impairment.
    Nie K; Li Y; Zhang J; Gao Y; Qiu Y; Gan R; Zhang Y; Wang L
    Front Neurol; 2022; 13():897867. PubMed ID: 35860484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.